Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.51−0.02 (-1.31%)
Close on Nov 18, 2026Market cap $1.98MP/E –Yield –
Can-Fite BioPharma free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was -$8.95M. The highest annual figure on record is -$4.19M in fiscal 2018.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.95M | – |
| FY2024 | Dec 31, 2024 | -$7.64M | – |
| FY2023 | Dec 31, 2023 | -$8.44M | – |
| FY2022 | Dec 31, 2022 | -$10.81M | – |
| FY2021 | Dec 31, 2021 | -$9.87M | – |
| FY2020 | Dec 31, 2020 | -$12.09M | – |
| FY2019 | Dec 31, 2019 | -$11.09M | – |
| FY2018 | Dec 31, 2018 | -$4.19M | – |
| FY2017 | Dec 31, 2017 | -$8.98M | – |
| FY2016 | Dec 31, 2016 | -$8.72M | – |
| FY2015 | Dec 31, 2015 | -$4.86M | – |
See a number that looks wrong?